| Interferon beta-1a |
EU/1/98/063/009 |
Rebif, Solution for injection, 44 mcg/0,5 ml-1,5 ml, mcg, Pack: 4 |
Merck Serono Europe Limited, Обединено Кралство |
Merck Serono S.p.A., Италия |
1517.45 |
303.49 |
1820.94 |
4% |
10 |
1527.45 |
305.49 |
1832.94 |
16% |
25 |
1552.45 |
310.49 |
1862.94 |
|
НСР-4560/03.09.2014 |
18.09.2014 |
18.09.2014 |
Неактивен |
3162 |
| Interferon beta-1a |
EU/1/98/063/005 |
REBIF, Solution for injection, 44 mcg - 0.5 ml, -, Pack: 3 pre-filled syringe |
Merck Europe B.V., Нидерландия |
Merck Serono S.p.A. - Италия |
344.77 |
68.95 |
413.72 |
4% |
10 |
354.77 |
70.95 |
425.72 |
16% |
25 |
379.77 |
75.95 |
455.72 |
Промяна на обстоятелства НСР-18318/28.03.2019 |
НСР-5681/18.02.2015.; НСР-9208/ 05.05.2016; НСР-13549/18.08.2017 |
02.09.2017 |
02.05.2019 |
Активен |
3593 |
| Interferon beta-1a |
EU/1/98/063/005 |
REBIF, Solution for injection, 44 mcg - 0.5 ml, -, Pack: 3 pre-filled syringe |
Merck Serono Europe Limited, Обединено Кралство |
Merck Serono S.p.A. - Италия |
344.77 |
68.95 |
413.72 |
4% |
10 |
354.77 |
70.95 |
425.72 |
16% |
25 |
379.77 |
75.95 |
455.72 |
|
НСР-5681/18.02.2015.; НСР-9208/ 05.05.2016; НСР-13549/18.08.2017 |
02.09.2017 |
02.10.2017 |
Неактивен |
3593 |
| Interferon beta-1a |
EU/1/98/063/005 |
REBIF, Solution for injection, 44 mcg - 0.5 ml, -, Pack: 3 pre-filled syringe |
Merck Serono Europe Limited, Обединено Кралство |
Merck Serono S.p.A. - Италия |
353.11 |
70.62 |
423.73 |
4% |
10 |
363.11 |
72.62 |
435.73 |
16% |
25 |
388.11 |
77.62 |
465.73 |
|
НСР-5681/18.02.2015.; НСР-9208/ 05.05.2016 |
02.06.2016 |
02.06.2016 |
Неактивен |
3593 |
| Interferon beta-1a |
EU/1/98/063/005 |
REBIF, Solution for injection, 44, mcg, Pack: 3 |
Merck Serono Europe Limited, Обединено Кралство |
Merck Serono S.p.A. - Италия |
377.67 |
75.53 |
453.2 |
4% |
10 |
387.67 |
77.53 |
465.2 |
16% |
25 |
412.67 |
82.53 |
495.2 |
|
НСР-5681/18.02.2015. |
05.03.2015 |
05.03.2015 |
Неактивен |
3593 |
| Interferon beta-1a |
EU/1/98/063/005 |
REBIF, Solution for injection, 44, mcg, Pack: 3 |
Merck Serono Europe Limited, Обединено Кралство |
Merck Serono S.p.A. - Италия |
388.78 |
77.76 |
466.54 |
4% |
10 |
398.78 |
79.76 |
478.54 |
16% |
25 |
423.78 |
84.76 |
508.54 |
|
НСР-1882/27.11.2013 |
17.12.2013 |
17.12.2013 |
Неактивен |
3593 |
| Interferon beta-1a |
EU/1/98/063/005 |
REBIF, Solution for injection, 44, mcg, Pack: 3 |
Merck Serono Europe Limited, Обединено Кралство |
Merck Serono S.p.A. - Италия |
410.31 |
82.06 |
492.37 |
4% |
10 |
420.31 |
84.06 |
504.37 |
16% |
25 |
445.31 |
89.06 |
534.37 |
|
КЦРР-2187/06.02.2013 |
04.03.2013 |
04.03.2013 |
Неактивен |
3593 |
| Interferon beta-1a |
EU/1/98/063/005 |
REBIF, Solution for injection, 44, mcg, Pack: 3 |
Merck Serono Europe Limited, Обединено Кралство |
Merck Serono S.p.A. - Италия |
460.56 |
92.11 |
552.67 |
4% |
10 |
470.56 |
94.11 |
564.67 |
16% |
25 |
495.56 |
99.11 |
594.67 |
|
КЦ-1521/23.04.2010 |
10.05.2010 |
10.05.2010 |
Неактивен |
3593 |
| Coagulation factor VIII (Octocog alfa) |
II-6325/ 27.11.2009 |
Recombinate 1000 IU, Powder and solvent for solution for injection, 1000, IU, Pack: 1 |
Baxter AG, Австрия |
Baxter SA - Belgium |
1055.11 |
211.02 |
1266.13 |
4% |
10 |
1065.11 |
213.02 |
1278.13 |
16% |
25 |
1090.11 |
218.02 |
1308.13 |
цената се заличава КЦРР-1549/01.11.2012 |
КЦРР-259/06.03.2012 |
21.03.2012 |
21.03.2012 |
Заличен |
1147 |
| Coagulation factor VIII (Octocog alfa) |
II-6325/27.11.2009 |
Recombinate 1000 IU, Powder and solvent for solution for injection, 1000, IU, Pack: 1 |
Baxter AG, Австрия |
Baxter SA - Belgium |
1167.59 |
233.52 |
1401.11 |
6% |
15 |
1182.59 |
236.52 |
1419.11 |
18% |
30 |
1212.59 |
242.52 |
1455.11 |
|
КЦ-1571/10.05.2010 |
02.06.2010 |
02.06.2010 |
Неактивен |
1147 |
| Coagulation factor VIII (Octocog alfa) |
II-6323 /27.11.2009 |
Recombinate 250 IU, Powder and solvent for solution for injection, 250, IU, Pack: 1 |
Baxter AG, Австрия |
Baxter SA - Belgium |
263.63 |
52.73 |
316.36 |
4% |
10 |
273.63 |
54.73 |
328.36 |
16% |
25 |
298.63 |
59.73 |
358.36 |
цената се заличава КЦРР-2102/25.01.2013 |
КЦРР-259/06.03.2012 |
21.03.2012 |
21.03.2012 |
Заличен |
1145 |
| Coagulation factor VIII (Octocog alfa) |
II-6323/27.11.2009 |
Recombinate 250 IU, Powder and solvent for solution for injection, 250, IU, Pack: 1 |
Baxter AG, Австрия |
Baxter SA - Belgium |
291.73 |
58.35 |
350.08 |
6% |
15 |
306.73 |
61.35 |
368.08 |
18% |
30 |
336.73 |
67.35 |
404.08 |
|
КЦ-1571/10.05.2010 |
02.06.2010 |
02.06.2010 |
Неактивен |
1145 |
| Coagulation factor VIII (Octocog alfa) |
II-6324/ 27.11.2009 |
Recombinate 500 IU, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Baxter AG, Австрия |
Baxter SA - Belgium |
527.57 |
105.51 |
633.08 |
4% |
10 |
537.57 |
107.51 |
645.08 |
16% |
25 |
562.57 |
112.51 |
675.08 |
цената се заличава КЦРР-2102/25.01.2013 |
КЦРР-259/06.03.2012 |
21.03.2012 |
21.03.2012 |
Заличен |
1146 |
| Coagulation factor VIII (Octocog alfa) |
II-6324/27.11.2009 |
Recombinate 500 IU, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Baxter AG, Австрия |
Baxter SA - Belgium |
583.8 |
116.76 |
700.56 |
6% |
15 |
598.8 |
119.76 |
718.56 |
18% |
30 |
628.8 |
125.76 |
754.56 |
|
КЦ-1571/10.05.2010 |
02.06.2010 |
02.06.2010 |
Неактивен |
1146 |
| Coagulation factor VIII (Moroctocog alfa) |
EU/1/99/103/006 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 pre filled syringe + 1 plunger rod + 1 sterile infusion set + 2 alcohol swabs + 1 plaster + 1 gauze + 1 vented sterile cap |
Pfizer Europe MA EEIG, Белгия |
Wyeth Farma S.A, Испания |
501.28 |
100.26 |
601.54 |
4% |
10 |
511.28 |
102.26 |
613.54 |
16% |
25 |
536.28 |
107.26 |
643.54 |
Промяна на обстоятелства НСР-17477/13.12.2018 |
НСР-7531/19.11.2015 |
05.12.2015 |
02.01.2019 |
Активен |
3640 |
| Coagulation factor VIII (Moroctocog alfa) |
EU/1/99/103/006 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 pre filled syringe + 1 plunger rod + 1 sterile infusion set + 2 alcohol swabs + 1 plaster + 1 gauze + 1 vented sterile cap |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A, Испания |
501.28 |
100.26 |
601.54 |
4% |
10 |
511.28 |
102.26 |
613.54 |
16% |
25 |
536.28 |
107.26 |
643.54 |
|
НСР-7531/19.11.2015 |
05.12.2015 |
05.12.2015 |
Неактивен |
3640 |
| Coagulation factor VIII (Moroctocog alfa) |
EU/1/99/103/006 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 pre filled syringe + 1 plunger rod + 1 sterile infusion set + 2 alcohol swabs + 1 plaster + 1 gauze + 1 vented sterile cap |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A, Испания |
501.28 |
100.26 |
601.54 |
4% |
10 |
511.28 |
102.26 |
613.54 |
16% |
25 |
536.28 |
107.26 |
643.54 |
|
НСР-7531/19.11.2015 |
05.12.2015 |
05.12.2015 |
Неактивен |
3640 |
| Coagulation factor VIII (Moroctocog alfa) |
EU/1/99/103/006 |
ReFacto AF, Powder and solvent for solution for injection, 500 IU, -, Pack: 1 pre filled syringe + 1 plunger rod + 1 sterile infusion set + 2 alcohol swabs + 1 plaster + 1 gauze + 1 vented sterile cap |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A, Испания |
501.28 |
100.26 |
601.54 |
4% |
10 |
511.28 |
102.26 |
613.54 |
16% |
25 |
536.28 |
107.26 |
643.54 |
|
НСР-7531/19.11.2015 |
05.12.2015 |
05.12.2015 |
Неактивен |
3640 |
| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/002 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Pfizer Europe MA EEIG, Белгия |
Wyeth Farma S.A.. Autovia del Norte Испания |
506.4 |
101.28 |
607.68 |
4% |
10 |
516.4 |
103.28 |
619.68 |
16% |
25 |
541.4 |
108.28 |
649.68 |
Промяна на обстоятелства НСР-17756/17.01.2019 |
НСР-7012/25.08.2015; НСР-11065/01.12.2016 г.; НСР-18103/07.03.2019 |
22.03.2019 |
02.04.2019 |
Активен |
2453 |
| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/002 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Pfizer Europe MA EEIG, Белгия |
Wyeth Farma S.A.. Autovia del Norte Испания |
508.5 |
101.7 |
610.2 |
4% |
10 |
518.5 |
103.7 |
622.2 |
16% |
25 |
543.5 |
108.7 |
652.2 |
Промяна на обстоятелства НСР-17756/17.01.2019 |
НСР-7012/25.08.2015; НСР-11065/01.12.2016 г. |
17.12.2016 |
02.02.2019 |
Неактивен |
2453 |
| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/002 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A.. Autovia del Norte Испания |
508.5 |
101.7 |
610.2 |
4% |
10 |
518.5 |
103.7 |
622.2 |
16% |
25 |
543.5 |
108.7 |
652.2 |
|
НСР-7012/25.08.2015; НСР-11065/01.12.2016 г. |
17.12.2016 |
02.01.2017 |
Неактивен |
2453 |
| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/002 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A.. Autovia del Norte Испания |
508.5 |
101.7 |
610.2 |
4% |
10 |
518.5 |
103.7 |
622.2 |
16% |
25 |
543.5 |
108.7 |
652.2 |
|
НСР-7012/25.08.2015; НСР-11065/01.12.2016 г. |
17.12.2016 |
02.01.2017 |
Неактивен |
2453 |
| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/002 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A.. Autovia del Norte Испания |
520.11 |
104.02 |
624.13 |
4% |
10 |
530.11 |
106.02 |
636.13 |
16% |
25 |
555.11 |
111.02 |
666.13 |
|
НСР-7012/25.08.2015 |
10.09.2015 |
10.09.2015 |
Неактивен |
2453 |
| Coagulation factor VIII (Moroctocog alfa) |
ЕU/1/99/103/002 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A.. Autovia del Norte Испания |
520.11 |
104.02 |
624.13 |
4% |
10 |
530.11 |
106.02 |
636.13 |
16% |
25 |
555.11 |
111.02 |
666.13 |
|
НСР-7012/25.08.2015 |
10.09.2015 |
10.09.2015 |
Неактивен |
2453 |
| Coagulation factor VIII (Moroctocog alfa) |
EU/1/99/103/006 |
ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Pfizer Limited, Обединено Кралство |
Wyeth Farma S.A, Испания |
520.11 |
104.02 |
624.13 |
4% |
10 |
530.11 |
106.02 |
636.13 |
16% |
25 |
555.11 |
111.02 |
666.13 |
|
НСР-5767/09.03.2015 |
23.03.2015 |
23.03.2015 |
Неактивен |
3640 |